Pengujian Kinerja Pembangkit Listrik Tenaga Surya

In order to investigate the behavior of the solar home systems, 10 data loggers have been installed in three different villages in Kolaka district in Southeast Sulawesi in March 2001. The solar home systems installed in Kolaka consists of a 50 Wp Solarex MSX 50 modules, 70 Ah battery, 10A/12volt battery charge regulator (BCR) and three 6W fluorescent lights. This paper will present and elaborate the performance of solar home systems, which includes Vbattery, VLoad, ILoad, Imodule and comparison between theoretical calculation and field measurement. Results of monitoring nine solar home systems in Kolaka district in Indonesia are presented. Data logger information shows typical load patterns, and differences between users. The information allows for break-down of a number of different energy loss categories. Some of these losses can be reduced by the user

Penelitian Penerapan Pembangkit Listrik Tenaga Surya Dan Dampaknya Terhadap Lingkungan

Indonesia through government programmes and private sector activities. An assessment on performance of photovoltaic systems and study of their impacts was established in Kolaka, South-east Sulawesi. At the moment there are 2270 solar home systems (SHS) in this location. During the research and study, there are 9 data loggers have been installed in nine solar home systems in 4 villages of Kolaka. These data loggers were used to monitor and measure some parameters such as solar insolation , VBattery,VLoad, ILoad, IModule, and room temperature. Besides performance data collection above, a quantitative research method was done to explore the quality of life of rural and remotepeoples. 175 questionnaires were used to collect the data from households in 4 villages Polinggona, Popalia, Petudua dan Pewisoa Jaya. This paper will discuss resuts of the measurement of solar home systems, the impact on daily life of villagers and global and local environmental impact of the use of solar home systems

Growth and characterisation of CuIn_xGa_1_-_xSe_2 single crystals and device fabrication

SIGLEAvailable from British Library Document Supply Centre- DSC:DX181370 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Validasl Spesiflkasi Campuran Biodiesel-solar Hasil Pengukuran dengan Metoda Perhitungan Sederhana

Biodiesel is a fuel derived from vegetable oil or animal fats that can be used as an additive to or entirely replace conventional petroleum diesel fuel. In most cases, biodiesel is mixed with conventional diesel because of the higher cost of biodiesel, product availability and engine compatibility issues. In Indonesia, the decree No. 3675K/24/DJM/2006 regarding the quality and specification of diesel oil type Solsr 48 and Solar 51 has been issued this decree regulates the use of FAME (fatty acid methyl ester) up to the maximum of 10 percent of the volume of automotive diesel fuel with which it is to be blended. The cost to measure the properlles of fuel is expensive and time consuming, therefore it is important to develop a simple method to predict those blending properties. This paper presents the development of a simple calculation method for the validation of blend palm biodiesel-mineral diesel specification (density, viscosity, cetane number and lubricity) which has been measured in the author's previous study The result shows that the lubricity and viscosity shows a higher average error value (difference value between calculation and measurement result) of 1.66% and 1.35%, whereas density and cetane number shows lower average error values of 0.06 and 0.6%. The average error value less than 2% is still acceptable

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations

INTRODUCTION:Maintenance treatment with macrolides are useful in preventing COPD exacerbations. We investigated which characteristics of COPD patients with frequent exacerbations predicted the best response to maintenance treatment with azithromycin. METHODS:This study was part of the COLUMBUS trial, a prospective randomized, double-blind, placebo-controlled study in 92 COPD patients with frequent exacerbations. During the 1-year treatment period, follow-up data were collected for spirometry, mMRC scores, sputum cultures and blood inflammatory markers. RESULTS:In the azithromycin group a significant lower number of exacerbations per patient was observed in patients with the following characteristics: baseline blood eosinophil count ≥2.0% (x̄ = 1.26), compared to an eosinophil count < 2.0% (x̄ = 2.50; p = 0.02), GOLD stage 1-2 (x̄ = 1.06), versus GOLD stage 4 (x̄ = 2.62; p = 0.02) and GOLD group C (x̄ = 0.45) compared to group D (x̄ = 2.18; p < 0.01). Moreover, the number of hospitalizations was significantly lower in patients, with a blood eosinophil count ≥2.0% (x̄ = 0.26) compared to an eosinophil count < 2.0% (x̄ = 0.90; p = 0.01) and in GOLD stages 1-2 (x̄ = 1.06) compared to stage 4 (x̄ = 2.62; p = 0.04). CONCLUSION:In conclusion, azithromycin maintenance treatment appears to be effective in COPD patients with frequent exacerbations, who are either classified in GOLD stage 1-2 or GOLD C and those with a blood eosinophil count of ≥2.0%

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations

INTRODUCTION:Maintenance treatment with macrolides are useful in preventing COPD exacerbations. We investigated which characteristics of COPD patients with frequent exacerbations predicted the best response to maintenance treatment with azithromycin. METHODS:This study was part of the COLUMBUS trial, a prospective randomized, double-blind, placebo-controlled study in 92 COPD patients with frequent exacerbations. During the 1-year treatment period, follow-up data were collected for spirometry, mMRC scores, sputum cultures and blood inflammatory markers. RESULTS:In the azithromycin group a significant lower number of exacerbations per patient was observed in patients with the following characteristics: baseline blood eosinophil count ≥2.0% (x̄ = 1.26), compared to an eosinophil count < 2.0% (x̄ = 2.50; p = 0.02), GOLD stage 1-2 (x̄ = 1.06), versus GOLD stage 4 (x̄ = 2.62; p = 0.02) and GOLD group C (x̄ = 0.45) compared to group D (x̄ = 2.18; p < 0.01). Moreover, the number of hospitalizations was significantly lower in patients, with a blood eosinophil count ≥2.0% (x̄ = 0.26) compared to an eosinophil count < 2.0% (x̄ = 0.90; p = 0.01) and in GOLD stages 1-2 (x̄ = 1.06) compared to stage 4 (x̄ = 2.62; p = 0.04). CONCLUSION:In conclusion, azithromycin maintenance treatment appears to be effective in COPD patients with frequent exacerbations, who are either classified in GOLD stage 1-2 or GOLD C and those with a blood eosinophil count of ≥2.0%

Occurrence of virus-induced COPD exacerbations during four seasons

In this study, we investigated the occurrence of viral infections in acute exacerbations of chronic obstructive pulmonary disease (COPD) during four seasons. Viral infections were detected by the use of real-time reverse transcriptase polymerase chain reaction on pharyngeal swabs. During a 12-month period pharyngeal swabs were obtained in 136 exacerbations of 63 patients. In 35 exacerbations (25.7%) a viral infection was detected. Most viral infections occurred in the winter ( n = 14, 40.0%), followed by summer ( n = 9, 25.7%), autumn ( n = 6, 17.1%), and spring ( n = 6, 17.1%). Rhinovirus was the most frequently isolated virus ( n = 19, 51.4%), followed by respiratory syncytial virus ( n = 6, 16.2%), human metapneumovirus ( n = 5, 13.5%), influenza A ( n = 4, 10.8%), parainfluenza 4 ( n = 2, 5.4%), and parainfluenza 3 ( n = 1, 2.7%). This study showed that virus-induced COPD exacerbations occur in all four seasons with a peak in the winter months. However, the distribution of rhinovirus infections showed a different pattern, with most infections occurring in July